ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Clinical trials for ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS explained in plain language.
Never miss a new study
Get alerted when new ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS trials appear
Sign up with your email to follow new studies for ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for ulcerative colitis sufferers?
Disease control Recruiting nowThis study tests a new drug called SHR-1139 in 20 adults with moderate-to-severe ulcerative colitis, a chronic bowel disease. The treatment has two parts: a 12-week induction phase and a 48-week maintenance phase. The main goal is to see if the drug can improve symptoms by week 1…
Matched conditions: ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 26, 2026 09:53 UTC
-
New pill HRS-7085 aims to tame ulcerative colitis in early trial
Disease control Recruiting nowThis study tests an experimental tablet called HRS-7085 in 66 adults with moderate to severe ulcerative colitis, a chronic bowel disease. Participants are randomly assigned to receive either the drug or a placebo to see if it safely improves symptoms like diarrhea and rectal blee…
Matched conditions: ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 19, 2026 11:49 UTC